ISSN Druckformat: 2151-805X
Volumes:Volumen 10, 2019 Volumen 9, 2018 Volumen 8, 2017 Volumen 7, 2016 Volumen 6, 2015 Volumen 6, 2015 Volumen 5, 2014 Volumen 5, 2014 Volumen 5, 2014 Volumen 5, 2014 Volumen 4, 2013 Volumen 4, 2013 Volumen 4, 2013 Volumen 4, 2013 Volumen 3, 2012 Volumen 3, 2012 Volumen 2, 2011 Volumen 2, 2011 Volumen 2, 2011 Volumen 2, 2011 Volumen 1, 2010 Volumen 1, 2010 Volumen 1, 2010 Volumen 1, 2010
Ethics in Biology, Engineering and Medicine: An International Journal
Pain Medicine, Biotechnology, and Market Effects: Tools, Tekne, and Moral Responsibility
Departments of Neurology and Biochemistry, and the Neuroethics Studies Program, Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, D.C.
Tanabe Research Labs USA, 4540 Towne Centre Court, San Diego, California 92121
Mark V. Boswell
Department of Anesthesiology and Perioperative Medicine, University of Louisville School of Medicine, Louisville, KY, 40202 , USA
Despite advances in neurotechnology, pain remains a subjective experience that cannot be identified solely through objective means. The technological turn has led to and been synergized by market effects within medicine. In this paper we pose that this has led to 1) sidestepping of the discriminative intellectual integrity of science to inform and sustain the good of medicine, 2) diversion and/or subversion of physicians’ capacity to make wellinformed clinical decisions, 3) the excessive use (if not misuse) of certain technologies and technologically-based techniques, 4) a compromised 'discretionary space' in which physicians may use technology to uphold patients' best interest(s) and 5) a decremented medical fiduciary. In response, we propose four principal goals that could enable a more integrative use of technology. These are 1) promotion of 'customary' and 'out of the box' basic and clinical science as needed for new technologies in more personalized therapeutic settings and regimes, 2) eliminating unnecessary, inapt or inconsequential use(s) of technology, 3) development and provision of healthcare coverage that enables use of high technology as necessary and appropriate, and 4) incorporation of this insurance system within a broad Samaritan ethic of care.
Articles with similar content:
Immunometabolic Signaling Pathways Contribute to Macrophage and Dendritic Cell Function
Critical Reviews™ in Immunology, Vol.36, 2016, issue 5
Aditya P. Dandekar, Lucas T. Jennelle, Tshifhiwa Magoro, Young S. Hahn
"DO THEY EVEN HAVE THAT ANYMORE": THE IMPACT OF REDESIGNING A MINORITY ENGINEERING PROGRAM
Journal of Women and Minorities in Science and Engineering, Vol.18, 2012, issue 3
Teri J. Murphy, Randa Shehab, Cindy E. Foor
Abstract of "Ethics and Biomedical Engineering for the Twenty-First Century"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
RETHINKING HOW WE SUPPORT ONLINE LEARNING IN THE AGE OF ISOLATION AND INFORMATION ABUNDANCE: AN INTRODUCTION TO THE CREATE SYSTEM
International Journal on Innovations in Online Education, Vol.1, 2017, issue 3
THE ROLE OF SOCIAL CAPITAL IN AFRICAN AMERICAN STEM MENTORING RELATIONSHIPS
Journal of Women and Minorities in Science and Engineering, Vol.26, 2020, issue 2
|Digitales Portal||Digitale Bibliothek||eBooks||Zeitschriften||Referenzen und Berichte||Forschungssammlungen|